Skip to content

Electrical stimulation of external auditory canal combined with acupuncture in the treatment of tinnitus of damage of kidney-essnce: a randomized controlled study

Electrical stimulation of external auditory canal combined with acupuncture in the treatment of tinnitus of damage of kidney-essnce: a randomized controlled study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046339
Enrollment
Unknown
Registered
2021-05-14
Start date
2021-05-14
Completion date
Unknown
Last updated
2021-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tinnitus of damage of kidney-essnce

Interventions

Sponsors

Chengdu Renpin Ear, Nose and Throat Specialist Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Subjective symptoms of tinnitus (in line with the diagnostic criteria of "Chinese Medicine Otorhinolaryngology"), tinnitus in one or both ears, with or without hearing loss; 2. The tinnitus has been recurrent for more than 1 month or lasted more than 5 days; 3. The first onset time <= 5 years; 4. Aged 18 to 80 years; 5. Patients with tinnitus with kidney essence loss based on syndrome differentiation; 6. The informed consent form has been signed.

Exclusion criteria

Exclusion criteria: 1. Those who are accompanied by ear foreign bodies, inflammation, tumors, deformities, trauma, etc., who are found to be tinnitus caused by space-occupying lesions by otology examination, as well as objective deafness, total deafness and tinnitus; 2. There are obvious epidemic and infectious diseases in the near future or before the occurrence of tinnitus, such as herpes zoster auris, meningitis, mumps, measles, etc.; 3. Those who cooperate with other treatment methods at the same time, or those who still receive other treatments within 2 weeks before the start of this observation; 4. Patients during pregnancy or lactation, and those who are allergic to drugs; 5. Patients with severe primary diseases such as heart, liver, kidney and hematopoietic system, mental illness; 6. Others who do not meet the inclusion criteria and cannot evaluate the efficacy and safety.

Design outcomes

Primary

MeasureTime frame
Tinnitus visual analogue scale;

Secondary

MeasureTime frame
tinnitus handicap inventory;Hhearing loss classification;

Countries

China

Contacts

Public ContactHuang Ligao

Chengdu Renpin Ear, Nose and Throat Specialist Hospital

26547476@qq.com+86 28 87337925 8505

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026